The effort of all participants, volunteers and donors truly impacts the fight against cancer. Below is an example of the strides made within the past year.
For the first time, the FDA has approved a drug—KeyTruda—for cancer-based disease genetics rather than the site of a tumor. KeyTruda now can be used for colon, pancreatic, stomach, ovarian and other cancers if genetic testing reveals defects in so-called mismatch repair. The clinical trials for KeyTruda were conducted at the Johns Hopkins Bloomberg-Kimmel Institute. Swim Across America was the first organization to believe in the KeyTruda research project and provide grant funding for KeyTruda clinical trials. In total, over $2.6 million in proceeds from SAA—Baltimore have funded clinical trials and lifesaving research at Johns Hopkins.
You can make a credit card donation here, or send a check directly to the swimmer you are supporting, or to Swim Across America, P.O. Box 217, Larchmont, NY 10538.